Novaliq is a pharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the first and only water-free technology worldwide for ophthalmology products. EyeSol® is designed to unleash the full potential of eye care treatments.
EyeSol® enhances corneal residence time and ocular coverage, providing better bioavailability and faster onset. EyeSol® products are water-free and therefore obviate preservatives.
With an initial focus on dry eye disease (DED), Novaliq offers an industry-leading portfolio addressing today’s unmet medical needs of millions of patients with eye diseases.